Aruna Mahendravada

1.6k total citations
15 papers, 1.3k citations indexed

About

Aruna Mahendravada is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Aruna Mahendravada has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Immunology and 1 paper in Hematology. Recurrent topics in Aruna Mahendravada's work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Aruna Mahendravada is often cited by papers focused on CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Aruna Mahendravada collaborates with scholars based in United States and Italy. Aruna Mahendravada's co-authors include Barbara Savoldo, Gianpietro Dotti, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Aaron E. Foster, Biagio De Angelis, Ming Zhang, Valentina Hoyos and Concetta Quintarelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Aruna Mahendravada

15 papers receiving 1.3k citations

Peers

Aruna Mahendravada
Dayenne G. van Leeuwen United States
Aurore Morello United States
David E Ambrose United States
Sang M. Nguyen United States
Brock Lanier United States
ChingLam W. Wong United States
Katherine T. Marcucci United States
Yuriko Fujita Japan
Raghuveer Ranganathan United States
Lingfeng Liu United States
Dayenne G. van Leeuwen United States
Aruna Mahendravada
Citations per year, relative to Aruna Mahendravada Aruna Mahendravada (= 1×) peers Dayenne G. van Leeuwen

Countries citing papers authored by Aruna Mahendravada

Since Specialization
Citations

This map shows the geographic impact of Aruna Mahendravada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aruna Mahendravada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aruna Mahendravada more than expected).

Fields of papers citing papers by Aruna Mahendravada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aruna Mahendravada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aruna Mahendravada. The network helps show where Aruna Mahendravada may publish in the future.

Co-authorship network of co-authors of Aruna Mahendravada

This figure shows the co-authorship network connecting the top 25 collaborators of Aruna Mahendravada. A scholar is included among the top collaborators of Aruna Mahendravada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aruna Mahendravada. Aruna Mahendravada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Duong, MyLinh, Aruna Mahendravada, Kelly Sharp, et al.. (2020). Preclinical Development of Inducible MyD88/CD40 (iMC)-Enhanced Chimeric Antigen Receptor Natural Killer (GoCAR-NK) Cells to Target BCMA+ Tumors. Blood. 136(Supplement 1). 39–40. 1 indexed citations
2.
Collinson-Pautz, Matthew R., Wei-Chun Chang, An Lu, et al.. (2019). Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia. 33(9). 2195–2207. 64 indexed citations
3.
Sun, Chuang, Aruna Mahendravada, Brandon Ballard, et al.. (2019). Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma. Oncotarget. 10(24). 2369–2383. 77 indexed citations
4.
5.
Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2017). Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40. Molecular Therapy. 25(9). 2176–2188. 93 indexed citations
6.
Slawin, Kevin M., Aruna Mahendravada, Nicholas Shinners, et al.. (2016). Inducible MyD88/CD40 to allow rimiducid-dependent activation for control of proliferation and survival of chimeric antigen receptor (CAR) T cells targeting prostate stem cell antigen (PSCA).. Journal of Clinical Oncology. 34(2_suppl). 206–206. 2 indexed citations
7.
Foster, Aaron E., MyLinh Duong, An Lu, et al.. (2016). Inducible MyD88/CD40 (iMC) Costimulation Provides Ligand-Dependent Tumor Eradication By CD123-Specific Chimeric Antigen Receptor T Cells. Blood. 128(22). 4551–4551. 2 indexed citations
8.
Foster, Aaron E., Peter S. Chang, Pei‐Yi Lin, et al.. (2016). Efficacy and safety of Her2-targeted chimeric antigen receptor (CAR) T cells using MyD88/CD40 costimulation and iCaspase-9 suicide switch.. Journal of Clinical Oncology. 34(15_suppl). 3050–3050. 1 indexed citations
9.
Foster, Aaron E., Peter S. Chang, Pei‐Yi Lin, et al.. (2015). MyD88/CD40-based costimulation to enhance survival and proliferation of chimeric antigen receptor (CAR)-modified T cells.. Journal of Clinical Oncology. 33(15_suppl). 3064–3064. 2 indexed citations
10.
Foster, Aaron E., Aruna Mahendravada, Nicholas Shinners, et al.. (2015). Inducible MyD88/CD40 Allows Rimiducid-Dependent Activation to Control Proliferation and Survival of Chimeric Antigen Receptor-Modified T Cells. Blood. 126(23). 4295–4295. 2 indexed citations
11.
Foster, Aaron E., Aruna Mahendravada, Peter S. Chang, et al.. (2014). Inducible MyD88/CD40 Allows AP1903-Dependent Costimulation to Control Proliferation and Survival of Chimeric Antigen Receptor-Modified T Cells. Blood. 124(21). 1121–1121. 1 indexed citations
12.
Perna, Serena, Daria Pagliara, Aruna Mahendravada, et al.. (2013). Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition. Clinical Cancer Research. 20(1). 131–139. 115 indexed citations
13.
Perna, Serena, Biagio De Angelis, Daria Pagliara, et al.. (2012). Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma. Clinical Cancer Research. 19(1). 106–117. 63 indexed citations
14.
Hoyos, Valentina, Barbara Savoldo, Concetta Quintarelli, et al.. (2010). Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia. 24(6). 1160–1170. 455 indexed citations
15.
Stasi, Antonio Di, Biagio De Angelis, Cliona M. Rooney, et al.. (2009). T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 113(25). 6392–6402. 449 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dayenne G. van Leeuwen Breakdown of academic impact, for papers by Aurore Morello Breakdown of academic impact, for papers by David E Ambrose Breakdown of academic impact, for papers by Sang M. Nguyen Breakdown of academic impact, for papers by Brock Lanier Breakdown of academic impact, for papers by ChingLam W. Wong Breakdown of academic impact, for papers by Katherine T. Marcucci Breakdown of academic impact, for papers by Yuriko Fujita Breakdown of academic impact, for papers by Raghuveer Ranganathan Breakdown of academic impact, for papers by Lingfeng Liu
Rankless by CCL
2026